Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study

• WAKITA Atsushi

  Division of Hematology and Oncology, Nagoya City West Medical Center

• OHTAKE Shigeki

  Department of Clinical Laboratory Science, Kanazawa University Graduate School of Medical Science

• TAKADA Satoru

  Leukemia Research Center, Saiseikai Maebashi Hospital

• YAGASAKI Fumiharu

  Department of Hematology, Saitama Medical University International Medical Center

• KOMATSU Hirokazu

  Department of Medical Oncology and Immunology, Graduate School of Medical Sciences, Nagoya City University

• MIYAZAKI Yasushi

  The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine

• KUBO Kohmei

  Department of Hematology, Aomori Prefectural Central Hospital

• KIMURA Yukihiko

  Division of Hematology, First Department of Internal Medicine, Tokyo Medical University

• TAKESHITA Akihiro

  Internal Medicine III, Hamamatsu University School of Medicine

• ADACHI Yoko

  Department of Internal Medicine, Kobe Central Hospital of Insurance

• KIYOI Hitoshi

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• YAMAGUCHI Takuhiro

  Division of Biostatistics, Tohoku University Graduate School of Medicine

• YOSHIDA Minoru

  Fourth Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine

• OHNISHI Kazunori

  Oncology Center, Hamamatsu University School of Medicine

• MIYAWAKI Shuichi

  Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital

• NAOE Tomoki

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• UEDA Ryuzo

  Department of Medical Oncology and Immunology, Graduate School of Medical Sciences, Nagoya City University

• OHNO Ryuzo

  Aichi Cancer Center

Journal

• Int J Hematol

  Int J Hematol 96 (1), 84-93, 2012-07-01

Keywords

• Acute myeloid leukemia
• Elderly
• Response-oriented individualized induction therapy
• Daunorubicin
• Behenoyl cytarabine (enocitabine, BHAC)

Details

• CRID: 1571135650753618304
• NII Article ID: 10030954605
• NII Book ID: AA10797094
• ISSN: 09255710
• Text Lang: en
• Data Source:
  • CiNii Articles